Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.22 - $6.7 $37,966 - $114,583
-17,102 Reduced 36.29%
30,030 $67,000
Q1 2022

May 16, 2022

SELL
$4.18 - $13.39 $205,689 - $658,895
-49,208 Reduced 51.08%
47,132 $292,000
Q4 2021

Feb 14, 2022

BUY
$11.35 - $97.17 $982,490 - $8.41 Million
86,563 Added 885.37%
96,340 $1.22 Million
Q3 2021

Nov 15, 2021

BUY
$52.0 - $120.21 $211,900 - $489,855
4,075 Added 71.47%
9,777 $896,000
Q2 2021

Aug 16, 2021

SELL
$31.88 - $58.66 $5,323 - $9,796
-167 Reduced 2.85%
5,702 $302,000
Q1 2021

May 17, 2021

SELL
$28.6 - $49.21 $508,050 - $874,166
-17,764 Reduced 75.17%
5,869 $211,000
Q4 2020

Feb 16, 2021

BUY
$27.78 - $56.93 $656,524 - $1.35 Million
23,633 New
23,633 $657,000

Others Institutions Holding CRTX

About Cortexyme, Inc.


  • Ticker CRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,150,800
  • Market Cap $70.5M
More about CRTX
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.